47.288356, 7.939630
Siegfried
Zofingen, Switzerland
- Verified lead
- Marcel Imwinkelried
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
- Review cycle
- May 2026
- Full address
- Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland
- Site coordinates
- 47.288356, 7.939630
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Siegfried leadership page confirming Marcel Imwinkelried as CEO.
- Editorial note
- Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
GMP manufacturing network, Multi-site pharmaceutical quality systems
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Siegfried
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply · Global CDMO manufacturing
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
- Lead
- Marcel Imwinkelried (verified ↗)
- Address
- Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland (source ↗)
- Compliance
- GMP manufacturing network
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global CDMO manufacturing
- Capabilities
- API Manufacturing · Finished-Dose Production · CDMO Supply Operations
- Founded
- 1873
- Headcount
- 1001-5000
- Company page (open ↗)
Marcel Imwinkelried
Chief Executive Officer
Official Siegfried Zofingen location page listing Untere Brühlstrasse 4, Zofingen.
Open sourceGlobal CDMO manufacturing
Zofingen, Switzerland. CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply. Review completed on 14 Mar 2026.
Swiss, EU, and global pharmaceutical manufacturing oversight
GMP manufacturing network, Multi-site pharmaceutical quality systems
CDMO Manufacturing, APIs, and Finished-Dose Pharmaceutical Supply
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Siegfried located?
- Siegfried operates from Untere Brühlstrasse 4, CH-4800 Zofingen, Switzerland, Zofingen, Switzerland.
- Who runs Siegfried?
- Siegfried is led by Marcel Imwinkelried, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Siegfried hold?
- Siegfried is documented under GMP manufacturing network.
- What does Siegfried do?
- Siegfried enters the Swiss cluster layer with a 2026 CEO transition already visible on the official leadership page and a live multi-site production profile. Core capabilities: API Manufacturing, Finished-Dose Production, CDMO Supply Operations.
Related technical briefs
Briefs that name Zofingen as a covered market or city.
